NEW YORK, March 2 (GenomeWeb) - Isis Pharmaceuticals today said that it has received a two-year contract from the US Defense Advanced Research Projects Agency worth up to $19.5 million for development of a biosensor to identify infectious agents in biological warfare attacks.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.